ABK Biomedical is a unique Y90 microspheres and bland embolic microspheres company. Our proprietary Eye90 microspheres® and Easi-Vue™ microspheres are produced at our Halifax, Nova Scotia manufacturing facility.
Click the images below to check out our state of the art manufacturing facility in more detail.
Radiopaque Microspheres for Bland Embolization
Bob Abraham, MD, CMO at ABK Medical recently presented the latest advances in radioembolization at the GEST 2019 Annual Meeting.
Click the link on the left to view and download Dr Abrahams presentation
Biomedical Physics & Engineering Express – August 2019
ABK Biomedical and collaborators from Dalhousie University and MD Anderson Cancer Center in Houston recently published a paper entitled Quantification of the inherent radiopacity of glass microspheres for precision dosimetry in yttrium-90 radioembolization.
Click the link on the left to view and download the abstract for this peer reviewed publication
ABK Biomedical Inc. provides and continues to provide accurate information on its website. However, ABK Biomedical Inc. assumes no responsibility for accuracy and/or completeness, express or implied, as to the information contained or omitted and/or the products described. Furthermore, ABK Biomedical may change the products mentioned at any time without notice. ABK Biomedical Inc. is a Pre-clinical stage company engaged in the active research and development of new medical devices. ABK Biomedical products are considered investigational only and are not FDA cleared for use..
(C) Copyright 2019 – All International Rights Reserved – ABK Biomedical Inc.